Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Dec;29(6):771-5.
doi: 10.1007/s11596-009-0620-4. Epub 2009 Dec 29.

EGCG enhances TRAIL-mediated apoptosis in human melanoma A375 cell line

Qin Shen  1 , Fen Tian, Ping Jiang, Yanqiu Li, Li Zhang, Jingjing Lu, Jiawen Li
Affiliations

EGCG enhances TRAIL-mediated apoptosis in human melanoma A375 cell line

Qin Shen et al. J Huazhong Univ Sci Technolog Med Sci. 2009 Dec.

Abstract

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising anti-cancer agent. Epigallocatechin-3-gallate (EGCG) is a polyphenolic constituent of green tea. In this study, inhibitory effect of combined use of EGCG and TRAIL on human melanoma A375 cells was examined and the possible mechanism investigated. The cells were divided into 4 groups: control group, EGCG group (EGCG: 10, 20 mug/mL), TRAIL group (TRAIL: 25 ng/mL) and EGCG+TRAIL group (combined group). The growth inhibition was measured in the A375 cells treated with different concentrations of TRAIL ((25, 50, 75, 100, 125, 150 ng/mL) by MTT assay. The apoptosis was assessed by flow cytometry. The expressions of DR4 and DR5 were detected by flow cytometry and western blotting. The activities of caspase-8 and caspase-3 were determined by colorimetric assay. The results showed that TRAIL could dose-dependently inhibit the growth of A375 cells and the IC(50) of TRAIL was 150 ng/mL. The apoptosis rate was 11.8% in the TRAIL group, 5%-7% in the EGCG group and 48.9%-59.1% in the combined group. Significant difference was found in the apoptosis rate between the combined group and the EGCG or TRAIL group (P<0.05 for each). The expression of DR4 instead of DR5 was significantly increased in the EGCG group. The activity of caspase-3 rather than caspase-8 was substantially enhanced in the EGCG group. These results suggest that EGCG is useful for the TRAIL-based treatment for melanoma.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Oncogene. 2007 May 17;26(23):3364-77 - PubMed
    1. Cell Death Differ. 2004 Oct;11(10):1121-32 - PubMed
    1. Prostate. 2004 Sep 15;61(1):35-49 - PubMed
    1. Antioxid Redox Signal. 2004 Jun;6(3):571-82 - PubMed
    1. J Natl Cancer Inst. 1993 Jul 7;85(13):1038-49 - PubMed

MeSH terms

LinkOut - more resources

-